Cervical Cancer treatment hailed as most Remarkable Breakthrough in 20 years: Scientists

Published On 2023-10-27 11:00 GMT | Update On 2023-10-28 11:28 GMT

In a groundbreaking development, the INTERLACE phase III trial, sponsored by Cancer Research UK and conducted by researchers from UCL and UCLH, has unveiled promising results for the treatment of locally advanced cervical cancer. The study, spanning a decade and involving 500 patients across multiple countries, revealed that a brief course of induction chemotherapy (IC) followed by standard chemoradiation (CRT) reduced the risk of death or cancer recurrence by 35%.

Notably, patients who received IC followed by CRT exhibited a five-year survival rate of 80%, with 73% remaining free from cancer relapse, compared to 72% survival and 64% relapse-free rates in the group receiving standard CRT alone. A key advantage of this approach is the affordability and accessibility of the drugs employed in IC, carboplatin and paclitaxel, which are already approved and widely available.

Reference:

M. McCormack, D. Gallardo Rincón, G. Eminowicz, P. Diez, LBA8 A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE trial, Annals of Oncology, DOI:https://doi.org/10.1016/j.annonc.2023.10.028

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Cervical Cancer treatment hailed as most Remarkable Breakthrough in 20 years: Scientists

Similar News

New Liquid Biopsy May Detect HPV-Related Cancers 10 Years Before Symptoms: Study Finds

How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out

New Urine Test May Detect Prostate Cancer with 91 Percent Accuracy: Study

India Sees Higher Cancer Incidence in Women but Greater Mortality in Men: ICMR Study

This Diet May Cut Risk of Cancer and Heart Disease Multimorbidity: Study Suggests

Real-World Case: Managing Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Akhil Kapoor

One Workout May Trigger Tumor-Suppressing Proteins in Cancer Survivors: Study Shows

New Web-Based Tool Aims to Cut Lung Cancer Deaths with Tailored Strategies, Reveals Research